📢“If they have anything that’s going on, they’re unafraid to say ‘Hey, something just doesn’t feel right...” ⚕️Hear how Coach @DawnStaley protected player mental health while @GamecockWBB took home the National Championship in the national spotlight at https://t.co/F6GCe1dn0D!

🏥 “ASCs reduced Medicare costs by $28.7 billion from 2011 to 2018..." 🎙️ Mark of the @ASCAssociation joins us to discuss how ambulatory surgery centers are delivering high-quality care, expanding access, and driving major cost savings. 🔊 Tune in at https://t.co/g2dDmkLra4!

⚕️This week, we welcome Mark Wainner of the @ASCAssociation to explore how ambulatory surgery centers are transforming the health care landscape. Mark shares insights on regulatory changes, quality reporting, & overall industry growth. 🔊Tune in at https://t.co/g2dDmkLYZC!

⚕️Recorded at the @NCLifeSci 2025 Annual Meeting, we welcome Bobby Patrick of @AdvaMedUpdate, the world's largest medical technology association. Bobby highlights the policy and technology shaping the future of medtech. 🔊Tune in to episode 252 now at https://t.co/g2dDmkLYZC!

⚕️“Public health is involved with every aspect of our lives from seat belts… to helping people design communities so they’re walkable, bikeable, and green.” 🎙️Dr. Benjamin discusses making a public health a national priority. 🔊 Listen now at https://t.co/g2dDmkLYZC!

⚕️This week, we are joined by public health leader Dr. Georges C. Benjamin of the American Public Health Association (APHA). 🩺Dr. Benjamin shares how the APHA is advocating for Medicaid access, preparing for future health emergencies, & more. 🔊Tune in: https://t.co/g2dDmkLYZC

💊“It’d be really difficult to move manufacturing here … while also keeping drug prices down for patients.” Gil Roth of PBOA unpacks how tariffs, executive orders, & domestic manufacturing policies are reshaping the pharmaceutical landscape. Tune in at https://t.co/g2dDmkLYZC!

⚕️This week we are joined by Gil Roth, President of @PBOAssoc. Gil shares how CDMOs are navigating regulatory uncertainty, the potential impact of tariffs on drug pricing & supply chains, and what EOs could mean for innovation & access to care. Tune in at https://t.co/g2dDmkLYZC!

🏥 “North Carolina sends more children out of state for care than any other state in the country when it comes to acute care specialty... We think our citizens deserve a lot better.” — Andy Willis of @NCChildrens's 🔊Hear about NC's new hospital at https://t.co/g2dDmkLra4!

⚕️This episode we welcome Andy Willis of NC Children’s, a hospital being developed through a historic partnership between @UNC_Health_Care & @DukeHealth. 🔊Hear how NC Children’s is poised to become one of the top pediatric hospitals in the U.S. at https://t.co/g2dDmkLYZC!

⚕️“Most reputable treatment centers understand that addiction is a chronic relapsing disease... They’re saying, ‘We can help you on the journey,’ not ‘We’re going to cure you.’” 🔊 Hear more about how @yourAPNC is fighting patient brokering on ep 248 at https://t.co/g2dDmkLra4!

⚕️We are joined by Sara & Morgan of @yourAPNC for a powerful conversation about substance use treatment, patient brokering, & the importance of ethical care. 🔊Tune in for an inspiring episode on advocacy, recovery, & building resilient communities at https://t.co/g2dDmkLYZC!

🧪“The tumor microenvironment is very harsh to immune cells.” 🔊 Fangheng & Ming-Wei explain why solid tumors like ovarian cancer are so difficult to treat, & how RephImmune’s RACE-T technology is designed to overcome those barriers. Tune in at https://t.co/g2dDmkLra4!

🧬“We are helping your own cells save your own life." - Ming-Wei Chen, Founder & CEO of RephImmune 🔊 Ming-Wei and Fangheng join the podcast to share how RephImmune is reimagining cell therapy to fight solid tumors like ovarian cancer. Tune in now at https://t.co/g2dDmkLYZC!

🧬This week, Ming-Wei & Fangheng of RephImmune share how they're developing a cell therapy platform designed to overcome the limitations of CAR-T by re-engineering immune cells to better locate, penetrate, and survive in solid tumors. Tune in now at https://t.co/jDHlkAQZQH!

🧬“Our gene therapy treatment is a one & done treatment... Your gene copies are corrected & your onset of your disease is arrested.” Neal & Pawel share how Jaya Bio is pioneering gene therapy & precision medicine for Alzheimer’s & Parkinson’s. Listen at https://t.co/g2dDmkLYZC!

🧬On episode 246, Neal & Pawel of Jaya Bio share how their team is using precision medicine to target specific mutations linked to Alzheimer’s, Parkinson’s, and frontotemporal dementia, aiming to arrest disease progression with a single dose. Tune in at https://t.co/g2dDmkLra4!

⚕️“We don't think it should be the AI that's guiding care. We think it should be the human that's still guiding care, but making them as efficient and effective in their decision-making process as they possibly can be.” 🔊Tune in for more on AI at https://t.co/g2dDmkLra4!

⚕️This week, Angela Adams shares how @inflohealth uses AI to solve a critical gap in care: missed radiology follow-ups. 📈With 60% of recommended additional imaging going unaddressed, hear how smart technology can support providers & improve outcomes at https://t.co/g2dDmkLra4!

⚕️On ep 244, Ray Waldrup of The Leaders Rheum offers an inside look at the forces reshaping the future of independent care, from the impact of hospital and private equity ownership to the growing influence of insurance companies and PBMs. 🔊Tune in at https://t.co/g2dDmkLra4!

⚕️“So if someone starts a business and they’re going to develop some sort of tech or device in the medical field... we have a lot of flexibility there.” @MaynardNexsen attorneys share how life sciences entrepreneurs can protect their assets. Tune in at https://t.co/g2dDmkLra4!